Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Constellation Energy CorpCEG · Entity 2918 | EVP & Chief Generation Officer | February 09, 2026 | February 11, 2026 |
| EXELON CORPEXC · Entity 3050 | EVP & Chief Generation Officer | January 28, 2022 | February 01, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Constellation Energy Corp
Report date February 09, 2026 · Filed February 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 114,363 |
Reported balance
After 2026-02-09 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2026-02-09 · Exercise / conversion · Acquired 53,507 · Balance 114,363 F1: Shares of Common Stock acquired from vested equity awards granted under the Issuer's Long-term Incentive Plan ("LTIP"). |
| Common StockSEC Table I · non-derivative | Direct | 92,197 |
Reported balance
After 2026-02-09 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2026-02-09 · Tax withholding · Disposed 22,166 · Balance 92,197 |
| Common StockSEC Table I · non-derivative | Direct | 65,609 |
Reported balance
After 2026-02-09 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2026-02-09 · Disposition to issuer · Disposed 26,587 · Balance 65,609 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,536 |
Reported balance
After 2026-02-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-09 · Exercise / conversion · Disposed 7,331 · Balance 4,536 F2: Restricted stock units ("RSUs") vest in 1/3 increments on the dates of the Compensation Committee's first-quarter meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Common Stock upon vesting, and does not expire. These RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Issuer's board of directors, which vest on the same schedule as the underlying RSU award. F3: The RSU award acquired approximately 65 additional shares through automatic dividend reinvestment since February 10, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,508 |
Reported balance
After 2026-02-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-02-09 · Grant · Acquired 4,972 · Balance 9,508 F2: Restricted stock units ("RSUs") vest in 1/3 increments on the dates of the Compensation Committee's first-quarter meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Common Stock upon vesting, and does not expire. These RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Issuer's board of directors, which vest on the same schedule as the underlying RSU award. |
| 2023-2025 Performance SharesSEC Table II · derivative / convertible security | Direct | 46,176 |
Reported balance
After 2026-02-09 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-02-09 · Grant · Acquired 46,176 · Balance 46,176 F4: Performance share award granted under the LTIP for the three-year performance period referenced in Column 1 based upon the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share of Common Stock upon vesting. These performance shares do not accrue quarterly dividends. Performance share award vests immediately on the grant date. |
| 2023-2025 Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-09 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-02-09 · Exercise / conversion · Disposed 46,176 · Balance 0 F4: Performance share award granted under the LTIP for the three-year performance period referenced in Column 1 based upon the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share of Common Stock upon vesting. These performance shares do not accrue quarterly dividends. Performance share award vests immediately on the grant date. |
| Common Stock (ESPP shares)SEC Table I · non-derivative | Direct | 2,204 |
Reported balance
Holding disclosure · report date 2026-02-09 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,204 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Common Stock acquired from vested equity awards granted under the Issuer's Long-term Incentive Plan ("LTIP").
F2: Restricted stock units ("RSUs") vest in 1/3 increments on the dates of the Compensation Committee's first-quarter meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Common Stock upon vesting, and does not expire. These RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Issuer's board of directors, which vest on the same schedule as the underlying RSU award.
F3: The RSU award acquired approximately 65 additional shares through automatic dividend reinvestment since February 10, 2025.
F4: Performance share award granted under the LTIP for the three-year performance period referenced in Column 1 based upon the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share of Common Stock upon vesting. These performance shares do not accrue quarterly dividends. Performance share award vests immediately on the grant date.
EXELON CORP
Report date January 28, 2022 · Filed February 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,371 |
Reported balance
After 2022-01-28 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2022-01-28 · Exercise / conversion · Acquired 14,491 · Balance 63,371 F1: Common shares acquired through conversion of previously granted and vested performance share award under the Exelon Long Term Incentive Plan. |
| Common StockSEC Table I · non-derivative | Direct | 57,226 |
Reported balance
After 2022-01-28 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2022-01-28 · Tax withholding · Disposed 6,445 · Balance 57,226 |
| Common StockSEC Table I · non-derivative | Direct | 49,180 |
Reported balance
After 2022-01-28 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2022-01-28 · Disposition to issuer · Disposed 8,046 · Balance 49,180 |
| Performance Shares 2019-2021SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 14,491 |
Reported balance
After 2022-01-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-01-28 · Grant · Acquired 14,491 · Balance 14,491 F2: Performance share award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share and/or cash pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately upon their grant date. |
| Performance Shares 2019-2021SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2022-01-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-01-28 · Exercise / conversion · Disposed 14,491 · Balance 0 F2: Performance share award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share and/or cash pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately upon their grant date. |
| Common Stock (ESPP shares)SEC Table I · non-derivative | Direct | 3,316 |
Reported balance
Holding disclosure · report date 2022-01-28 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,316 |
Filing footnotes · ownership attribution and instrument terms
F1: Common shares acquired through conversion of previously granted and vested performance share award under the Exelon Long Term Incentive Plan.
F2: Performance share award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share and/or cash pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately upon their grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 25, 2021 Filed Jan 26, 2021 22:33 UTC | EXELON CORP EXC · Entity 3050 | Disposition to issuerCommon Stock | 10,690 | $43.35 | $463,411.50 |
DisclosureSEC source: 0001062993-21-000645 · form4.xml · nonDerivative · entry 3 Hanson Bryan Craig · CIK 0001824653 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,295 Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:33 UTC | EXELON CORP EXC · Entity 3050 | Tax withholdingCommon Stock | 8,960 | $43.35 | $388,416.00 |
DisclosureSEC source: 0001062993-21-000645 · form4.xml · nonDerivative · entry 2 Hanson Bryan Craig · CIK 0001824653 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,985 Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:33 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionCommon Stock | 27,854 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-21-000645 · form4.xml · nonDerivative · entry 1 Hanson Bryan Craig · CIK 0001824653 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Common shares acquired through conversion of previously awarded and vested restricted stock units (RSUs) and performance share (stock units) under the Exelon Long Term Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.